secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bio Green Med Solution, Inc. (BGMS)
CIK:        0001130166
Form:       8-K
Filed at:   2025-09-16T23:59:59+00:00
Accession:  0001493152-25-013703
Event type: regulatory
Sentiment:  negative
Materiality: 0.60
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Bio Green Med receives Nasdaq deficiency notice for preferred stock (BGMSP) over minimum MVPHS
--------------------------------------------------------------------------------

- Nasdaq notified that BGMSP's Market Value of Publicly Held Shares fell below $1M for 30 consecutive business days.
- Company has 180 days until March 10, 2026 to regain compliance by achieving MVPHS of at least $1M for 10 consecutive days.
- Deficiency does not affect common stock (BGMS) listing; preferred stock continues to trade during cure period.
- Company will evaluate options if compliance not regained, including potential delisting and Nasdaq appeal process.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1130166/000149315225013703/0001493152-25-013703-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1130166/000149315225013703/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-013703

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer